Cleared Traditional

K073449 - SURGICASE

K073449 is an FDA 510(k) clearance for SURGICASE, manufactured by Materialise NV. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 128-day FDA review.

K073449 · Materialise NV · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2008
Decision
128d
Days
Class 2
Risk

K073449 is an FDA 510(k) clearance for the SURGICASE. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Materialise NV (Leuven, BE). The FDA issued a Cleared decision on April 16, 2008 after a review of 128 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Materialise NV devices

FDA 510(k) Submission Details - K073449

510(k) Number K073449 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 10, 2007
Decision Date April 16, 2008
Days to Decision 128 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
21d slower than avg
Panel avg: 107d · This submission: 128d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1969
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K073449.
DEXELA DEX TOP MAMMOGRAPHY WORKSTATION, MODEL MAMWKVI
K080351 · Dexela, Ltd. · Apr 2008
NM APPLICATION SUITE
K080961 · Philips Nuclear Medicine, Inc. · Apr 2008
DIGITAL LIGHTBOX
K080608 · Brainlab AG · Apr 2008
IMAGENMD WITH IMAGENQ
K080770 · Cardiovascular Imaging Technologies, LLC · Apr 2008
IGROK
K080325 · Igrok, LLC · Apr 2008
MIMICS
K073468 · Materialise NV · Apr 2008